Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer

The possible treatments options for metastatic hormone-sensitive prostate cancer (mHSPC) have dramatically increased during the last years. The old backbone, which androgen-deprivation therapy (ADT) is the exclusive approach for hormone-naïve patients, has been disrupted. Despite the fact t...

Full description

Bibliographic Details
Main Authors: Carlo Cattrini, Elena Castro, Rebeca Lozano, Elisa Zanardi, Alessandra Rubagotti, Francesco Boccardo, David Olmos
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
hormone-sensitive prostate cancer
hormone-naïve prostate cancer
docetaxel
enzalutamide
abiraterone acetate
apalutamide
radiotherapy
Online Access:https://www.mdpi.com/2072-6694/11/9/1355

Internet

https://www.mdpi.com/2072-6694/11/9/1355

Similar Items